Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share (the "Shares")
-
Shares outstanding
-
45,443,984
-
Total 13F shares
-
1,729,786
-
Share change
-
-289,128
-
Total reported value
-
$2,748,707
-
Price per share
-
$1.59
-
Number of holders
-
18
-
Value change
-
-$2,930,633
-
Number of buys
-
8
-
Number of sells
-
11
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (NERV) as of Q4 2022
As of 31 Dec 2022,
Minerva Neurosciences, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (NERV) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,729,786 shares.
The largest 10 holders included
FEDERATED HERMES, INC., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and MORGAN STANLEY.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.